EVH Valuation

Evolent Health Inc

Add to Watchlist

Advanced Chart

9.580

-0.03(-0.312%)1D

Overview
Forecast
Valuation
Earnings

EVH Relative Valuation

EVH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, EVH is overvalued; if below, it's undervalued.

Historical Valuation

Evolent Health Inc (EVH) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.52 is considered Undervalued compared with the five-year average of 22.90. The fair price of Evolent Health Inc (EVH) is between 16.61 to 33.69 according to relative valuation methord. Compared to the current price of 9.58 USD , Evolent Health Inc is Undervalued By 42.34%.

Relative Value

Fair Zone

16.61-33.69

Current Price：9.58

42.34%

Undervalued

18.46

Trailing

Forward

12.36

EV/EBITDA

Evolent Health Inc. (EVH) has a current EV/EBITDA of 12.36. The 5-year average EV/EBITDA is 22.27. The thresholds are as follows: Strongly Undervalued below 4.85, Undervalued between 4.85 and 13.56, Fairly Valued between 30.99 and 13.56, Overvalued between 30.99 and 39.70, and Strongly Overvalued above 39.70. The current Forward EV/EBITDA of 12.36 falls within the Undervalued range.

16.31

EV/EBIT

Evolent Health Inc. (EVH) has a current EV/EBIT of 16.31. The 5-year average EV/EBIT is 74.88. The thresholds are as follows: Strongly Undervalued below -324.37, Undervalued between -324.37 and -124.75, Fairly Valued between 274.51 and -124.75, Overvalued between 274.51 and 474.13, and Strongly Overvalued above 474.13. The current Forward EV/EBIT of 16.31 falls within the Historic Trend Line -Fairly Valued range.

0.52

Evolent Health Inc. (EVH) has a current PS of 0.52. The 5-year average PS is 1.48. The thresholds are as follows: Strongly Undervalued below 0.31, Undervalued between 0.31 and 0.89, Fairly Valued between 2.06 and 0.89, Overvalued between 2.06 and 2.64, and Strongly Overvalued above 2.64. The current Forward PS of 0.52 falls within the Undervalued range.

10.48

P/OCF

Evolent Health Inc. (EVH) has a current P/OCF of 10.48. The 5-year average P/OCF is -47.27. The thresholds are as follows: Strongly Undervalued below -697.31, Undervalued between -697.31 and -372.29, Fairly Valued between 277.76 and -372.29, Overvalued between 277.76 and 602.78, and Strongly Overvalued above 602.78. The current Forward P/OCF of 10.48 falls within the Historic Trend Line -Fairly Valued range.

15.93

P/FCF

Evolent Health Inc. (EVH) has a current P/FCF of 15.93. The 5-year average P/FCF is 88.08. The thresholds are as follows: Strongly Undervalued below -370.39, Undervalued between -370.39 and -141.16, Fairly Valued between 317.31 and -141.16, Overvalued between 317.31 and 546.54, and Strongly Overvalued above 546.54. The current Forward P/FCF of 15.93 falls within the Historic Trend Line -Fairly Valued range.

Evolent Health Inc (EVH) has a current Price-to-Book (P/B) ratio of 1.24. Compared to its 3-year average P/B ratio of 2.65 , the current P/B ratio is approximately -53.16% higher. Relative to its 5-year average P/B ratio of 2.90, the current P/B ratio is about -57.28% higher. Evolent Health Inc (EVH) has a Forward Free Cash Flow (FCF) yield of approximately -10.90%. Compared to its 3-year average FCF yield of 0.93%, the current FCF yield is approximately -1267.57% lower. Relative to its 5-year average FCF yield of -0.36% , the current FCF yield is about 2940.58% lower.

1.24

P/B

Median3y

2.65

Median5y

2.90

-10.90

FCF Yield

Median3y

0.93

Median5y

-0.36

Competitors Valuation Multiple

The average P/S ratio for EVH's competitors is 0.84, providing a benchmark for relative valuation. Evolent Health Inc Corp (EVH) exhibits a P/S ratio of 0.52, which is -37.57% above the industry average. Given its robust revenue growth of -31.34%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Healthcare Services Group Inc

Super X AI Technology Ltd

Montrose Environmental Group Inc

Performance Decomposition

Market capitalization of EVH decreased by 66.02% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -0.30 to -5.96.

The secondary factor is the Revenue Growth, contributed -31.34%to the performance.

Overall, the performance of EVH in the past 1 year is driven by P/E Change. Which is more unsustainable.

-31.34%

647.15M → 444.33M

Revenue Growth

-1892.00%

0.25 → -4.48

Margin Expansion

1857.32%

-0.30 → -5.96

P/E Change

-66.02%